Literature DB >> 17525131

Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.

C Alemán1, L Sanchez, J Alegre, E Ruiz, A Vázquez, T Soriano, J Sarrapio, J Teixidor, J Andreu, E Felip, L Armadans, T Fernández De Sevilla.   

Abstract

BACKGROUND: Which diagnostic procedures should be used to differentiate between idiopathic and malignant pleural effusions, is not well established. AIM: To identify which parameters allow differentiation between idiopathic and malignant pleural effusions.
DESIGN: Case-note review.
METHODS: Over a 12-year period, we treated 1014 consecutive pleural effusion patients, of whom 346 were diagnosed as having an idiopathic or malignant aetiology. We analysed medical history, chest X-ray, pleural fluid analysis (biochemical, microbiological and cytological), chest CT scan and additional examinations that were used according to clinical findings, and compared them with the eventual diagnosis and outcome.
RESULTS: Eighty-three patients with idiopathic effusions and 263 with malignant effusions were included. Idiopathic pleural effusion resolved in 47 patients, improved in 20 and persisted in 16. Biochemical pleural fluid analysis did not predict these outcomes. A history of neoplasm, chest X-ray and CT features, as well as additional examinations according to clinical findings, established a diagnosis or suspicion of malignancy in 256 (97.7%) of the 263 patients who received a diagnosis of malignant effusion. Diagnostic thoracoscopy was helpful in seven patients in whom malignant disease was strongly suspected, despite the absence of other pathological findings. DISCUSSION: Non-invasive complementary examinations generally allowed accurate differentiation between malignant and idiopathic effusions. Patients with idiopathic pleural effusions generally had favourable outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17525131     DOI: 10.1093/qjmed/hcm032

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  11 in total

1.  Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion.

Authors:  Y Murata; K Aoe; Y Mimura-Kimura; T Murakami; K Oishi; T Matsumoto; H Ueoka; K Matsunaga; M Yano; Y Mimura
Journal:  Clin Exp Immunol       Date:  2017-07-17       Impact factor: 4.330

2.  A potential role for VEGF in the diagnostic approach of pleural effusions.

Authors:  Aggeliki Psatha; Demosthenes Makris; Theodora Kerenidi; Zoe Daniil; Theodoros Kiropoulos; Konstantinos Gourgoulianis
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Clinical investigation of malignant mesothelioma in Japan.

Authors:  Nobukazu Fujimoto; Keisuke Aoe; Kenichi Gemba; Katsuya Kato; Koichi Yamazaki; Takumi Kishimoto
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

4.  The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions.

Authors:  Servet Kayhan; Aziz Gumus; Halit Cinarka; Naci Murat; Adnan Yilmaz; Recep Bedir; Unal Sahin
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

5.  Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.

Authors:  Jaume Trapé; Francesc Sant; Josefina Franquesa; Jesús Montesinos; Anna Arnau; Maria Sala; Oscar Bernadich; Esperanza Martín; Damià Perich; Concha Pérez; Joan Lopez; Sandra Ros; Enrique Esteve; Rafael Pérez; Jordi Aligué; Gabriel Gurt; Silvia Catot; Montserrat Domenech; Joan Bosch; Josep Miquel Badal; Mariona Bonet; Rafael Molina; Josep Ordeig
Journal:  Respir Res       Date:  2017-05-25

6.  Calprotectin: a novel biomarker for the diagnosis of pleural effusion.

Authors:  N Sánchez-Otero; S Blanco-Prieto; M Páez de la Cadena; L Vázquez-Iglesias; A Fernández-Villar; M I Botana-Rial; F J Rodríguez-Berrocal
Journal:  Br J Cancer       Date:  2012-10-23       Impact factor: 7.640

7.  Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.

Authors:  Yan Gu; Kan Zhai; Huan-Zhong Shi
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

8.  Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.

Authors:  Xirong Zhang; Haifeng Duan; Yong Yu; Chunling Ma; Zhanli Ren; Yuxin Lei; Taiping He; Ming Zhang
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

9.  Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.

Authors:  Yuan Yang; Li Ma; Xin Qiao; Xin Zhang; Shu-Feng Dong; Min-Ting Wu; Kan Zhai; Huan-Zhong Shi
Journal:  Transl Lung Cancer Res       Date:  2020-08

10.  A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.

Authors:  Jian Luo; Maoyun Wang; Chuntao Li; Binmiao Liang; Dan Liu; Chaoli Shi; Faming Jiang; Ting Wang; Peijun Li; Zongan Liang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.